We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$256M
AUM Growth
–
Cap. Flow
+$249M
Cap. Flow %
97.24%
Top 10 Hldgs %
46.55%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$19.3M
2
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$16.6M
3
FNSR
Finisar Corp
FNSR
+$15.2M
4
AKRX
Akorn Inc
AKRX
+$12.6M
5
EMKR
Emcore Corp
EMKR
+$10.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.52%
2 Technology 25.75%
3 Miscellaneous 16.74%
4 Consumer Staples 4.53%
5 Financials 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOV icon
76
NOV
NOV
$7.4B
$765K 0.3%
+12,315
New +$759K
PG icon
77
Procter & Gamble
PG
$333B
$755K 0.3%
+9,813
New +$770K
COV
78
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$747K 0.29%
+13,405
New +$775K
BMRN icon
79
BioMarin Pharmaceuticals
BMRN
$12.6B
$743K 0.29%
+13,337
New +$831K
LIFE
80
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$730K 0.29%
+9,868
New +$716K
EOG icon
81
EOG Resources
EOG
$75.8B
$728K 0.28%
+11,060
New +$709K
HTWR
82
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$701K 0.27%
+7,370
New +$671K
NUVA
83
DELISTED
NuVasive, Inc.
NUVA
$520K 0.2%
+20,974
New +$459K
PETX
84
DELISTED
Aratana Therapeutics, Inc.
PETX
$403K 0.16%
+53,295
New +$422K
VOLC
85
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$395K 0.15%
+21,766
New +$416K
UPI
86
DELISTED
UROPLASTY INC-NEW
UPI
$274K 0.11%
+132,211
New +$303K
HUM icon
87
Humana
HUM
$47.1B
$265K 0.1%
+3,145
New +$248K
WCRX
88
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$257K 0.1%
+12,905
New +$219K
VTI icon
89
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$256K 0.1%
+3,100
New +$257K
BMY icon
90
Bristol-Myers Squibb
BMY
$137B
$219K 0.09%
+4,895
New +$213K
PFE icon
91
Pfizer
PFE
$160B
$207K 0.08%
+7,800
New +$216K
PMCS
92
DELISTED
P M C SIERRA INC
PMCS
$127K 0.05%
+20,000
New +$122K
CORV
93
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$34K 0.01%
+17,280
New +$34.7K
1 2 3
4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Kopp Investment Advisors, which disclosed 93 positions worth $256M. Its ten largest holdings account for 47% of the portfolio.

Its largest position is Array Biopharma Inc: 3,587,128 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Technology and Miscellaneous.

  • Kopp Investment Advisors's largest Q2 2013 buy was Array Biopharma Inc: 3,587,128 shares worth $16.3M.
  • Kopp Investment Advisors's ten largest holdings make up 47% of its $256M portfolio in Q2 2013.
  • Kopp Investment Advisors disclosed 93 positions in Q2 2013, its first 13F filing on record.

Based on Kopp Investment Advisors's 13F filing for Q2 2013, filed 5 Aug 2013.